The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
- PMID: 29930287
- PMCID: PMC6013456
- DOI: 10.1038/s41598-018-27896-y
The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
Abstract
Whether the dynamic change of neutrophil to lymphocyte ratio (delta-NLR) can predict the outcome in various malignancies remained controversial. The delta-NLR has not been evaluated in colon cancer. Thus, we conducted the study to evaluate the predictive value of the delta-NLR in patients with colon cancer who underwent curative resection. Three-hundred and fifty-four patients with stage I-III colon cancer were retrospectively analysed. Clinicopathological features, preoperative NLR and postoperative NLR were collected. Prognostic factors were evaluated by univariate and multivariate analysis. The one, three and five-year overall survival rate in the delta-NLR < 0 group was 98.2%, 90.7% and 83.6%, respectively; and in the delta-NLR ≥ 0 group was 98.4%, 96.9% and 95.3%, respectively (log-rank test, P = 0.002). Univariate and multivariate analysis showed that there was a strong relationship between delta-NLR and overall survival. In conclusion, the delta-NLR was an independent prognostic factor for overall survival in early stage colon cancer. Patients with increased delta-NLR had an favourable clinical outcome.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.Anticancer Res. 2013 Oct;33(10):4591-4. Anticancer Res. 2013. PMID: 24123035
-
Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.Int J Colorectal Dis. 2010 Dec;25(12):1427-33. doi: 10.1007/s00384-010-1052-0. Epub 2010 Sep 7. Int J Colorectal Dis. 2010. PMID: 20821217
-
Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.J Surg Res. 2014 Dec;192(2):402-8. doi: 10.1016/j.jss.2014.05.078. Epub 2014 Jun 2. J Surg Res. 2014. PMID: 24998425
-
Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.J Med Assoc Thai. 2011 Jul;94(7):871-7. J Med Assoc Thai. 2011. PMID: 21774296
-
[Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):298-302. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24989918 Chinese.
Cited by
-
Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy.J Clin Med. 2022 Oct 16;11(20):6091. doi: 10.3390/jcm11206091. J Clin Med. 2022. PMID: 36294412 Free PMC article.
-
Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma.J Thorac Dis. 2019 Mar;11(3):819-826. doi: 10.21037/jtd.2019.02.02. J Thorac Dis. 2019. PMID: 31019770 Free PMC article.
-
Preoperative carcinoembryonic antigen to body mass index ratio contributes to prognosis prediction in colorectal cancer.Oncol Lett. 2022 Sep 29;24(5):416. doi: 10.3892/ol.2022.13536. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36245819 Free PMC article.
-
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.Discov Oncol. 2022 Dec 15;13(1):140. doi: 10.1007/s12672-022-00603-0. Discov Oncol. 2022. PMID: 36522513 Free PMC article.
-
Prognostic value of the fat-free mass index-based cachexia index in patients with colorectal cancer.Sci Rep. 2024 Oct 17;14(1):24390. doi: 10.1038/s41598-024-75485-z. Sci Rep. 2024. PMID: 39420045 Free PMC article.
References
-
- Torre LA, et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65:87–108. - PubMed
-
- Crozier JE, et al. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. British journal of cancer. 2006;94:1833–1836. doi: 10.1038/sj.bjc.6603185. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources